1,168
Views
16
CrossRef citations to date
0
Altmetric
Reports

Integrin-β4 is a novel transcriptional target of TAp73

, , , , , ORCID Icon & show all
Pages 589-594 | Received 25 Jul 2017, Accepted 29 Oct 2017, Published online: 08 Feb 2018
 

ABSTRACT

As a member of p53 family, p73 has attracted intense investigations due to its structural and functional similarities to p53. Among more than ten p73 variants, the transactivation (TA) domain-containing isoform TAp73 is the one that imitates the p53's behavior most. TAp73 induces apoptosis and cell cycle arrest, which endows it the capacity of tumour suppression. Also, it can exert diverse biological influences on cells through activating a complex and context dependent transcriptional programme. The transcriptional activities further broaden its roles in more intricate biological processes. In this article, we report that p73 is a positive regulator of a cell adhesion related gene named integrin β4 (ITGB4). This finding may have implications for the dissection of the biological mechanisms underlining p73 functions.

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

Additional information

Funding

This study was supported by the Medical Research Council, United Kingdom, by Associazione Italiana per la Ricerca contro il Cancro (AIRC): AIRC 2014 IG15653 (to G.M.), AIRC 5xmille MCO9979 (to G.M.) and AIRC 2011 IG11955 (to G.M.). G.M. and N.B. also acknowledge the support of RSF grant# 14-50-00068.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.